AI ECG could spot hidden heart rhythm risk before it strikes
NCT ID NCT07316231
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether an AI-enhanced 12-lead ECG can better identify people at risk for atrial fibrillation (AF), a major cause of stroke and heart failure. Researchers will enroll 350 adults with AF or atrial tachycardia who are in normal rhythm at the time of ECG recording. The AI analyzes the ECG to estimate hidden AF risk, and the team will track patients for 1-2 years to see if the AI's predictions match actual heart events.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-enhanced 12-lead ECG
What this could lead to
If successful, this AI tool could help doctors detect hidden atrial fibrillation earlier, potentially preventing strokes and heart failure.
What could go wrong
This is an observational registry, not a treatment trial. The AI's accuracy in real-world settings is still unproven, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toho University
RECRUITINGŌta-ku, Tokyo, 143-8540, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••